{"status":"success","data":{"title":"Neutropenic Fever and Cancer","slug":"cancer-neutropenic-fever","tags":["ciprofloxacin","vancomycin","cefipime","pipercillin-tazobactam","amoxicillin-clavulanate","aztreonam"],"collection":["hematology and oncology"],"content":"\n# Neutropenic Fever and Cancer\n\nChemotherapy causes neutropenia in 10-50% of patients with solid tumors and &gt; 80% of patients with hematologic malignancies during chemotherapy cycle\n\n**Fever:** ≥ 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period\n\n**Neutropenia:** Absolute neutrophil count &lt; 500 cells/mm3\n\n## MASCC score\n\n**Multinational Association for Supportive Care in Cancer (MASCC) Score:**\n\n|                                                                                                                   |                  |\n|-------------------------------------------------------------------------------------------------------------------|------------------|\n| **Burden of febrile neutropenia** | 5 pts (mild), 3 pts (moderate)  |\n| **No hypotension (SBP ≥ 90 mmHg)**                                                                                |  5 pts           |\n| **No COPD**                                                                                                       |  4 pts           |\n| **Solid tumor or hematologic malignancy <span class=\"drug\">with</span> no previous fungal infection**                                                                                |  4 pts           |\n| **No dehydration requiring parenteral fluids**                                                                    |  3 pts           |\n| **Outpatient status**                                                                                             |  3 pts           |\n| **Age &lt; 60 years**                                                                                             |  2 pts           |\n\n**HIGH RISK PATIENTS** (require admission):\n-   MASCC score &lt; 21 **OR**\n-   Any of clinical findings:\n    -   Prolonged (&gt; 7 days duration) and profound neutropenia (ANC ≤ 100 cells/mm3)\n    -   Hypotension\n    -   Pneumonia\n    -   New abdominal pain\n    -   Neurologic changes\n\n**LOW RISK PATIENTS** (may be eligible for outpatient tx):\n-   MASCC score ≥ 21\n-   Brief (≤ 7 days duration) neutropenic periods and few co-morbidities\n\n## Workup\n\n-   CBC, BUN/Creatinine, electrolytes, AST/ALT, bilirubin\n-   Chest xray, if respiratory signs or symptoms\n-   2 Blood Cx (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)\n\n## Antibiotic Treatment\n\n*Monotherapy:* Antipseudomonal beta-lactam (eg. **<span class=\"drug\">cefipime</span>, <span class=\"drug\">carbapenem</span>, <span class=\"drug\">pip-tazo</span>**)\n**<span class=\"drug\">Vancomycin</span>**is not always indicated in cancer patients with a neutropenic fever.\n-   Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant *Strep pneumoniae*\n\n*For PCN allergy*: **<span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">clindamycin</span>,** or **<span class=\"drug\">aztremonam</span> + <span class=\"drug\">vancomycin</span>**\n*For PO outpatient*: **<span class=\"drug\">Ciprofloxacin</span> + <span class=\"drug\">amoxicillin-clavulanate</span> **\n\n## Central line-associated blood stream infection (CLABSI)\n\n**Remove catheter:** Consider removal if any of following: \n\n-   Caused by *S. aureus*, *P. aeruginosa*, fungi, mycobacteria\n-   Tunnel infection\n-   Pocket site infection\n-   Septic thrombosis\n-   Endocarditis\n-   Sepsis with hemodynamic instability\n-   Bacteremia despite ≥ 72 hours antibiotics\n\n**Keep catheter** and treat with abx: If coag-negative staph\n\n## Example\n\nA 65 y/o man with a history of prostate cancer presents to your ED from home appearing fairly well and a mild cough for 3 days. He has otherwise no past medical problems. His vital signs are:\n\n-   Temperature 39 C\n-   BP 160/80\n-   HR 60\n-   RR 14\n-   Oxygen saturation 99% on room air\n\nHis absolute neutrophil count (ANC) comes back at 300 cells/mm3. His chest xray shows a right middle lobe pneumonia and a central line catheter tip ending in the SVC.\n\n**Questions:**\n\n-   Is this a patient \"high\" or \"low\" risk per the Multinational Association for Supportive Care in Cancer (MASCC)? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001575\">View answer</span>)\n-   Does this person require inpatient admission? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001576\">View answer</span>)\n-   What antibiotics would you start on this patient? (<span class=\"aglmd-moreinfo ui-moreinfo\" data-iid=\"53aa2472d35d3ae92e001577\">View answer</span>)\n\n## References\n\n-   [Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93.](http://www.ncbi.nlm.nih.gov/pubmed/21205990)\n"}}